文献速递皮肤肿瘤

黑色素瘤风险预测模型性能评估

Evaluating the Performance of Melanoma Risk Prediction Models.
PubMed 文献 · JAMA Dermatol · 2026-10-21

本研究在澳大利亚45岁及以上人群队列中评估6个已发表黑色素瘤风险预测模型的区分度和校准度,发现10年AUC范围为0.58至0.70,多数模型低估黑色素瘤发生数,部分模型需重新校准以改善绝对风险估计。

要点

  • 6个模型10年AUC为0.58至0.70,区分能力中等。
  • 多数模型低估队列中诊断的黑色素瘤数量。
  • 模型可用于风险分层,但人群水平绝对风险估计或需重新校准。

核心结论

  • 多个模型区分能力中等,与原始研究相当,支持用于风险分层以指导预防和早期检测。
  • 部分模型需重新校准以改善人群水平绝对风险估计。

研究设计与样本

  • 基于澳大利亚45 and Up研究队列的人群为基础研究,纳入完成2020年随访调查的参与者。
  • 通过链接新南威尔士州癌症登记处获取侵袭性黑色素瘤(所有模型)或侵袭性及原位黑色素瘤(1个模型)的诊断。

主要发现

  • 10年随访AUC范围为0.58(95%CI 0.56-0.60)至0.70(95%CI 0.68-0.72)。
  • 多数风险模型低估队列中诊断的黑色素瘤数量。
  • 校准最佳的两个模型校准-in-the-large值分别为-0.16(95%CI -0.20至-0.11;斜率0.74,95%CI 0.69-0.78)和0.59(95%CI 0.52-0.66;斜率0.72,95%CI 0.66-0.78)。
  • 分析样本中发生946例侵袭性和1406例原位黑色素瘤。

临床怎么用

  • 可将模型用于风险分层以指导预防和早期检测策略。
  • 在人群水平应用前,需考虑对模型进行重新校准以改善绝对风险估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Evaluation of melanoma risk prediction models in independent datasets is crucial for determining their potential utility for preventive strategies. OBJECTIVE: To assess the discrimination and calibration of 6 published melanoma risk prediction models in a large prospective longitudinal cohort in Australia. DESIGN, SETTING, AND PARTICIPANTS: This population-based study uses data from the Sax Institute's 45 and Up Study cohort, which includes 267 357 residents of New South Wales (NSW), Australia, aged 45 years or older, recruited through the Services Australia Medicare enrollment database in 2005 to 2009, with linked cancer data to December 31, 2019. The study sample included participants who completed the 2020 follow-up survey. Incident melanoma diagnoses were obtained through data linkage to the NSW Cancer Registry, separately for outcomes of invasive melanoma only (all models), or invasive and in situ melanoma (1 model). The data analysis occurred between May 2025 and February 2026. EXPOSURES: Risk factors for each risk model were assessed from baseline and 2020 follow-up questionnaires. MAIN OUTCOMES AND MEASURES: Main outcomes were discrimination and calibration measures for predicting 10-year risk of a first primary melanoma. RESULTS: A total of 45 061 participants completed the 2020 follow-up survey (52.8% response rate). The analysis sample included up to 43 235 participants (median [IQR] age, 57 [51-64] years; 24 159 [55.9%] female; 19 076 [44.1%] male), and 946 invasive and 1406 in situ incident melanomas. Discrimination assessed using the area under the receiver operating characteristic curve (AUC) at 10 years follow-up ranged from 0.58 (95% CI, 0.56-0.60) to 0.70 (95% CI, 0.68-0.72). Most risk models underestimated the number of melanomas diagnosed in the cohort; the 2 models with the best calibration had calibration in the large values of -0.16 (95% CI, -0.20 to -0.11]; slope, 0.74 [95% CI, 0.69-0.78]) and 0.59 (95% CI, 0.52-0.66]; slope, 0.72 [95% CI, 0.66-0.78]). CONCLUSIONS AND RELEVANCE: In this cohort study, several prediction models demonstrated moderate discriminatory performance comparable to their original studies, supporting their potential use for risk stratification to guide prevention and early detection strategies. Some recalibration may be needed to improve estimation of absolute risks at the population level.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Reyes-Marcelino G, Espinoza D, Smit AK, et al. Evaluating the Performance of Melanoma Risk Prediction Models. JAMA Dermatol. 2026. PMID: 42905683. doi:10.1001/jamadermatol.2026.4097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。